Advertisement

Diseases of the Kidney

  • Joseph E. Ross

Abstract

Despite advances in the treatment of acute renal failure (ARF), the overall mortality rate has improved little since the 1960s.1 ARF itself, regardless of other illnesses, increases the risk of severe complications and mortality.2 ARF complicates 5% of hospital and 30% of intensive care unit (ICU) admissions. Acute mortality approaches 50%; of those who survive ARF, 50% have persistent deterioration of renal function.1

Keywords

Nephrotic Syndrome Transitional Cell Carcinoma Autosomal Dominant Polycystic Kidney Disease Polycystic Kidney Disease Renal Cyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brady HR, Brenner BM, Lieberthal W. Acute renal failure. In: Brenner BM, editor. The kidney. Philadelphia: Saunders, 1996:1200–52.Google Scholar
  2. 2.
    Turney JH. Acute renal failure—a dangerous condition. JAMA 1996;275:1516–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson RK. Prevention and management of acute renal failure. Hosp Pract 1993;61–75.Google Scholar
  4. 4.
    Miller S.B. Renal diseases. In: Ewald GA, McKenzie CR, editors. Manual of medical therapeutics. 28th ed. Boston: Little, Brown, 1995:262–77.Google Scholar
  5. 5.
    Freidman EA. End-stage renal disease therapy. JAMA 1996; 275:1118–22.CrossRefGoogle Scholar
  6. 6.
    Bennett PH, Haffner S, Kasiske BL, et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee for the council on diabetes mellitus of the National Kidney Foundation. Am J Kidney Dis 1995;15:107–12.CrossRefGoogle Scholar
  7. 7.
    Lafayette RA. Preventing disease progression and chronic renal failure. Am Fam Physician 1995;52:1783–91.PubMedGoogle Scholar
  8. 8.
    Narins G, Cortes P. The role of dietary protein restriction in progressive azotemia. N Engl J Med 1994;330:929–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Jacobson HR, Striker GE. Report on workshops to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 1995; 25:103–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Hirsch IB. Current concepts in diabetic nephropathy. Clin Diabetes 1994;Jan/Feb:8–12.Google Scholar
  11. 11.
    Clark CM, Lee DA. Prevention and treatment of complications of diabetes mellitus. N Engl J Med 1995;332:1210–17.PubMedCrossRefGoogle Scholar
  12. 12.
    Solomon R. Strategies to delay renal deterioration. Patient Care 1995;25:50–8.Google Scholar
  13. 13.
    Mason PD, Pusey CD. Glomerulonephritis: diagnosis and treatment. BMJ 1994;309:1557–63.PubMedCrossRefGoogle Scholar
  14. 14.
    Anderson GA, Degroot D, Lawson RK. Polycystic renal disease. Urology 1993;42:358–64.PubMedCrossRefGoogle Scholar
  15. 15.
    Beebe DK. Autosomal dominant polycystic kidney disease. Am Fam Physician 1996;53:925–31.PubMedGoogle Scholar
  16. 16.
    Tores VE. Polycystic kidney disease: guidelines for family physicians. Am Fam Physician 1996;53:847–50.Google Scholar
  17. 17.
    Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:332–42.PubMedCrossRefGoogle Scholar
  18. 18.
    Grantham JJ. Polycystic kidney disease: hereditary and acquired. Adv Intern Med 1993;38:409–20.PubMedGoogle Scholar
  19. 19.
    Rutecki GW, Whittier FC. Polycystic kidney disease: detecting and managing extrarenal complications. Consultant 1995;Nov:1667–76.Google Scholar
  20. 20.
    Sene AP, Hunt L, McMahon RF, et al. Renal carcinoma in patients undergoing nephrectomy: analysis of survival and the prognostic factors. Br J Urol 1992;70:125–34.PubMedCrossRefGoogle Scholar
  21. 21.
    Krogh J, Kviste RB. Transitional cell carcinoma of the upper urinary tract: prognostic variables in postoperative reoccurrences. Br J Urol 1991;67:32–6.PubMedCrossRefGoogle Scholar
  22. 22.
    National Wilms Tumor Study Committee, Wilms tumor: status report, 1990. J Clin Oncol 1991;9:877–87.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Joseph E. Ross

There are no affiliations available

Personalised recommendations